Ken Fisher's IDXX Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 304 shares of IDEXX Laboratories, Inc. (IDXX) worth $205,881, representing 0.00% of the portfolio. First purchased in 2020-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in IDXX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2022, adding 13,602 shares. Largest reduction occurred in Q3 2023, reducing 40,677 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's IDEXX Laboratories (IDXX) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEXX Laboratories (IDXX) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2020 | +17,921 | New Buy | 17,921 | $330.17 |
| Q3 2020 | +277 | Add 1.55% | 18,198 | $393.12 |
| Q4 2020 | +987 | Add 5.42% | 19,185 | $499.87 |
| Q1 2021 | -1,764 | Reduce 9.19% | 17,421 | $489.29 |
| Q2 2021 | +2,243 | Add 12.88% | 19,664 | $631.56 |
| Q3 2021 | +829 | Add 4.22% | 20,493 | $621.92 |
| Q4 2021 | +1,381 | Add 6.74% | 21,874 | $658.45 |
| Q1 2022 | +7,783 | Add 35.58% | 29,657 | $547.05 |
| Q2 2022 | +493 | Add 1.66% | 30,150 | $350.75 |
| Q3 2022 | +13,602 | Add 45.11% | 43,752 | $325.81 |
| Q4 2022 | -906 | Reduce 2.07% | 42,846 | $407.97 |
| Q1 2023 | -742 | Reduce 1.73% | 42,104 | $500.08 |
| Q2 2023 | -772 | Reduce 1.83% | 41,332 | $502.23 |
| Q3 2023 | -40,677 | Reduce 98.42% | 655 | $437.44 |
| Q4 2023 | -260 | Reduce 39.69% | 395 | $555.37 |
| Q1 2024 | -395 | Sold Out | 0 | $0.00 |
| Q2 2024 | +831 | New Buy | 831 | $487.54 |
| Q3 2024 | -153 | Reduce 18.41% | 678 | $505.73 |
| Q4 2024 | +19 | Add 2.80% | 697 | $414.01 |
| Q1 2025 | -54 | Reduce 7.75% | 643 | $420.26 |
| Q2 2025 | -643 | Sold Out | 0 | $0.00 |
| Q4 2025 | +304 | New Buy | 304 | $677.24 |
Ken Fisher's IDEXX Laboratories Investment FAQs
Ken Fisher first purchased IDEXX Laboratories, Inc. (IDXX) in Q2 2020, acquiring 17,921 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held IDEXX Laboratories, Inc. (IDXX) for 22 quarters since Q2 2020.
Ken Fisher's largest addition to IDEXX Laboratories, Inc. (IDXX) was in Q2 2020, adding 17,921 shares worth $5.92 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 304 shares of IDEXX Laboratories, Inc. (IDXX), valued at approximately $205,881.
As of the Q4 2025 filing, IDEXX Laboratories, Inc. (IDXX) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in IDEXX Laboratories, Inc. (IDXX) was 43,752 shares, as reported at the end of Q3 2022.